Naoki Matsumoto

16PUBLICATIONS
20CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosisAcoustics and noise control (excl. architectural acoustics)Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Jun 30, 2026
Contrast-enhanced ultrasound findings are associated with tumor viability and depth of response in selected patients with unresectable hepatocellular carcinoma treated with immunotherapy-based combination therapy.

|Feb 27, 2026
Multiple Primary Malignancy-Related Gallbladder Cancer: An Important Recommendation for the Early Detection of Gallbladder Cancer.

Hiroko Naganuma, Hideaki Ishida, Naoki Matsumoto

|Nov 27, 2024
Artificial Intelligence and Image Analysis-Assisted Diagnosis for Fibrosis Stage of Metabolic Dysfunction-Associated Steatotic Liver Disease Using Ultrasonography: A Pilot Study.

Itsuki Fujii, Naoki Matsumoto, Masahiro Ogawa

|Feb 10, 2024
Correlation between pathology and quantitative ultrasonographic evaluation of pancreatic fat with ultrasonographic classification.

Naoki Matsumoto, Mariko Kumagawa, Kei Saito

|May 28, 2022
Suppressors of Cytokine Signaling and Hepatocellular Carcinoma.

Ryota Masuzaki, Tatsuo Kanda, Reina Sasaki

|Mar 31, 2022
Contrast-enhanced ultrasonography for blood flow detection in hepatocellular carcinoma during lenvatinib therapy.

Naoki Matsumoto, Masahiro Ogawa, Masahiro Kaneko

Pageof 3

Frequent Collaborators

4 joint publications

Tatsuo Kanda

3 joint publications

Ryota Masuzaki

2 joint publications

Hirofumi Kogure

2 joint publications

Reina Sasaki-Tanaka